Skip to content

Study of the treatment protocol for blepharitis

Study of the treatment protocol for blepharitis - Study of the treatment protocol for blepharitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000039106
Enrollment
100
Registered
2020-01-09
Start date
2019-12-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

blepharitis

Interventions

None listed

Sponsors

Miyata Eye Hospital
Lead Sponsor
Ishizuchi Eye Clnic Tane Memorial Eye Hospital Hattori Clinic Horikiri Eye Clinic Matsumoto Eye Clinic
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1 Male or female blepharitis patients who is 16 year old or older. 2 Patients with a total score of 4 or more of signs(eyelid redness/eyelid margin redness, eyelash discharge, and conjunctival hyperemia) and symptoms (foreign body sensation, lacrimation) and a score of 1 or more of eyelid redness/eyelid margin redness, and a score of 1 or more of symptoms. 3 Patients who can administer eye drops properly. 4 Patients who understands the contents of the consent document and is able to consent in the document of the person.

Exclusion criteria

Exclusion criteria: 1 Younger than 16 years old. 2 Patients with eyelid diseases (including entropion, eyelid tumor) other than blepharitis. 3 Patients with extraocular inflammatory diseases (including bacterial, fungal, viral, and allergic) other than blepharitis. 4 Patients with severe ocular surface disease. 5 Patients who use of any antibiotic, steroid or immunosuppressant (systemic or topical) within 2 week of enrollment.

Design outcomes

Primary

MeasureTime frame
Healing rate will be assessed at day 7 and 14.

Secondary

MeasureTime frame
Bacteria isolated from lid margin and clinical symptoms and signs at initial visit.

Countries

Japan

Contacts

Public ContactRyohei Nejima

Miyata Eye Hospital Ophthalmology

nejima@miyata-med.ne.jp0986-22-1441

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026